Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for CORMEDIX INC Common Stock (CRMD).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2024.
BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for CORMEDIX INC Common Stock (CRMD)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Security
- CORMEDIX INC Common Stock
- Symbol
- CRMD
- Shares outstanding
- 60,905,293 shares
- Disclosed Ownership
- 4,567,897 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2025, 13:23:34 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 7.5% ownership in CORMEDIX INC Common Stock (CRMD) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 13:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.5% | 4,567,897 | 4,521,593 | 0 | Spencer Fleming | Managing Director |